Christoph Sachse

Christoph Sachse is currently the Vice President Business Development Global at NUVISAN The Science CRO. Prior to this role, Christoph held various positions such as Co-Founder at ASC Oncology GmbH, Site Head Berlin at NMI TT Pharmaservices, and Interim Project Manager at siTOOLs Biotech GmbH. Christoph has a strong background in cell-based services, with experience as a Director and Group Leader at Cenix BioScience. Christoph has a PhD in Clinical Pharmacology from Charité, Humboldt University Berlin, and a MSc in Pharmacology and Toxicology from Martin Luther University Halle-Wittenberg.